DCZ-0415

N/A

Report date: 2022/01/10 11:26:47
NME

Base Information

Drug NameDCZ-0415
Drug Alias NameDCZ-0415
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPachytene checkpoint protein 2 homolog inhibitors
TargetsPachytene checkpoint protein 2 homolog
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Oriental Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Oriental Hospital
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A